Rockwell Medical
RMTI
#8471
Rank
NZ$0.21 B
Marketcap
$6.97
Share price
1.58%
Change (1 day)
112.15%
Change (1 year)

P/E ratio for Rockwell Medical (RMTI)

P/E ratio as of November 2024 (TTM): -4.76

According to Rockwell Medical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -4.76136. At the end of 2022 the company had a P/E ratio of -0.5401.

P/E ratio history for Rockwell Medical from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-0.5401-54.13%
2021-1.18-52.2%
2020-2.46-43.46%
2019-4.3619.53%
2018-3.65-68.06%
2017-11.4-30.31%
2016-16.4-53.63%
2015-35.382.05%
2014-19.4206.55%
2013-6.33107.5%
2012-3.05-56.44%
2011-7.00-86.71%
2010-52.7153.4%
2009-20.8182.74%
2008-7.35-67.24%
2007-22.425.88%
2006-17.8-103.99%
2005447325.71%
2004105-98.96%
2003> 1000-205454.94%
2002-4.92-12.2%
2001-5.60

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-88.4 1,756.43%๐Ÿ‡บ๐Ÿ‡ธ USA
7.04-247.84%๐Ÿ‡บ๐Ÿ‡ธ USA
38.8-914.74%๐Ÿ‡บ๐Ÿ‡ธ USA
347-7,382.27%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.